Mitel®, a global leader in business communications, has announced that its Virtual Care Collaboration Service (VCCS) has earned the prestigious title of “Virtual Workspace Platform of the Year” in the 5th Annual RemoteTech Breakthrough Awards by RemoteTech Breakthrough, a prominent…
The “Biosimilars Training Course” conference is now available through ResearchAndMarkets.com, providing a crucial opportunity to anticipate and capitalize on the imminent growth within the biosimilars market. As numerous prominent biologics approach patent expiration in the coming years, the landscape of…
Caldera Medical, a global leader in women’s pelvic health, proudly announces its sponsorship of the Cynisca cycling team. This partnership underscores Caldera Medical’s ongoing dedication to promoting women’s health and empowerment through sports and community involvement. Cynisca Cycling, an elite…
The report “Digital Twins in Healthcare Market, Industry Trends and Global Forecasts, till 2035 – Distribution by Therapeutic Area, Type of Digital Twin, Areas of Application, End Users and Key Geographical Regions” has been added to ResearchAndMarkets.com’s offerings. The global…
Genmab A/S (Nasdaq: GMAB) announced today that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting conditional marketing authorization for epcoritamab (TEPKINLY®). This T-cell engaging bispecific antibody is intended as a monotherapy for…
Pulse Biosciences, Inc. (Nasdaq: PLSE), leveraging its CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, disclosed today the preliminary outcomes of its recently concluded rights offering. The offering, which expired at 5:00 p.m. Eastern Time on June 26, 2024, set the…
Tebra, the comprehensive platform for independent healthcare providers, has announced multiple new product enhancements in the second quarter aimed at maximizing time spent with patients. This announcement coincides with the release of a recent survey revealing that 85% of independent…
Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, announced today that the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) has unanimously recommended CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine)…
ObjectiveHealth, a Nashville-based integrated research and technology platform company, has announced an expansion of its partnership with QualDerm Partners, LLC, a leading dermatology and skin care management services organization also based in Nashville. This collaboration aims to integrate clinical research…
Genoks, a leading genomics healthcare company based in Turkey, has partnered with Velsera, a global healthcare technology firm specializing in a universal software platform connecting clinical care with discovery. Together, they aim to advance cancer diagnostics and treatment not only…
Last year, Brenus Pharma was chosen to join CDL Cancer, a global mentoring program supporting highly scalable, science-driven companies advancing cancer treatments. Distinguished by its innovative STC platform focused on developing next-generation therapeutic cancer vaccines, Brenus impressed during a rigorous…
Augustine Therapeutics, a pioneering biotech firm dedicated to innovative therapies for neurodegenerative and cardiometabolic diseases, has successfully secured EUR 17 million (USD 18.5 million) in the initial closing of its Series A funding round. The financing was led by Asabys…